Skip to content
★ Sign in to follow
LL

Lutz Lingnau

Executive
Nektar TherapeuticsSirna Therapeutics Inc
Total declarations
33
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€5.6M

Latest filing published 25 Sept 2020 for NEKTAR THERAPEUTICS.

Filing timeline

BuySale
Lutz Lingnau

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Lutz Lingnau: trading record in brief

Lutz Lingnau has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Nektar Therapeutics and Sirna Therapeutics Inc. We count 33 filings; the first trade dates from 29 December 2006 and the latest from 22 September 2020.

On the market, this insider has only sold: 14 sales, €5.6M in total. The rest of the record consists of 6 share grants and 12 option exercises.

The newest entry dates from 25 September 2020: a share grant, in Nektar Therapeutics. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Lutz Lingnau

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total

25 of 33 declarations